Daniel Lee

Daniel Lee

Corporate Officer/Principal en
Society For Biomaterials
.

Fortuna: 27 356 $ al 31/10/2025

65 años
Health Technology
Consumer Services
Commercial Services

Perfil

Daniel R.
Lee
is currently a Member at the American Association of Tissue Banks and a Member at the Society For Biomaterials.
Former positions include Chief Executive Officer at Aperion Biologics, Inc. from 2008 to 2015; Chief Executive Officer & Director at Scaffold Biologics, Inc.; Chief Executive Officer & Director at Tissue Regenix Group Plc from 2020 to 2025; Chief Executive Officer at CellRight Technologies LLC from 2019 to 2025; Director-Research & Development at United States Surgical Corp.; Director-Marketing at Regeneration Technologies, Inc.; Marketing Director at OsteoBiologics, Inc. from 2003 to 2006; and Marketing Director at Smith & Nephew Endoscopy, Inc. from 2006 to 2008.
Education includes undergraduate studies at The Johns Hopkins University and graduate studies at The University of Alabama.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
31/12/2024 282.512 ( 0,4 % ) 27 356 $ 31/10/2025

Cargos activos de Daniel Lee

EmpresasCargoInicio
Corporate Officer/Principal -
Corporate Officer/Principal -

Antiguos cargos conocidos de Daniel Lee.

EmpresasCargoFin
Director Ejecutivo 21/10/2025
TISSUE REGENIX GROUP PLC Director Ejecutivo 16/10/2025
Ventas & Marketing 01/08/2008
Ventas & Marketing 01/07/2006
Scaffold Biologics, Inc.
Director Ejecutivo -
Ver el detalle de la experiencia de Daniel Lee.

Formación de Daniel Lee.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

23

Relaciones de 1er grado

12

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas12

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Commercial Services

Health Technology

Commercial Services

Distribution Services

Distribution Services

Scaffold Biologics, Inc.